| __timestamp | Geron Corporation | Lantheus Holdings, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 16758000 | 72429000 |
| Thursday, January 1, 2015 | 17793000 | 78634000 |
| Friday, January 1, 2016 | 18761000 | 75374000 |
| Sunday, January 1, 2017 | 19287000 | 92157000 |
| Monday, January 1, 2018 | 18707000 | 93326000 |
| Tuesday, January 1, 2019 | 20893000 | 103132000 |
| Wednesday, January 1, 2020 | 25678000 | 110171000 |
| Friday, January 1, 2021 | 29665000 | 218817000 |
| Saturday, January 1, 2022 | 43628000 | 233827000 |
| Sunday, January 1, 2023 | 69135000 | 267194000 |
Data in motion
In the competitive landscape of the healthcare sector, understanding the financial strategies of companies is crucial. Lantheus Holdings, Inc. and Geron Corporation, two prominent players, have shown distinct trends in their Selling, General, and Administrative (SG&A) expenses from 2014 to 2023.
Lantheus Holdings, Inc. has consistently outpaced Geron Corporation in SG&A spending, with a notable increase of approximately 270% over the decade. This growth reflects their aggressive expansion and investment in operational capabilities. In contrast, Geron Corporation's SG&A expenses have risen by about 310%, indicating a strategic shift towards scaling their operations.
The year 2023 marked a significant peak for both companies, with Lantheus Holdings, Inc. reaching nearly 2.67 times their 2014 expenses, while Geron Corporation saw a fourfold increase. These trends highlight the dynamic nature of financial management in the healthcare industry.
Novo Nordisk A/S or Lantheus Holdings, Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of Merck & Co., Inc. and Geron Corporation
Cost Management Insights: SG&A Expenses for Teva Pharmaceutical Industries Limited and Lantheus Holdings, Inc.
Breaking Down SG&A Expenses: United Therapeutics Corporation vs Lantheus Holdings, Inc.
Genmab A/S and Lantheus Holdings, Inc.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Intra-Cellular Therapies, Inc. vs Geron Corporation Trends and Insights
BioMarin Pharmaceutical Inc. vs Geron Corporation: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Lantheus Holdings, Inc. and Corcept Therapeutics Incorporated
Revenue Insights: Lantheus Holdings, Inc. and Geron Corporation Performance Compared
Cost Management Insights: SG&A Expenses for Lantheus Holdings, Inc. and Perrigo Company plc
Cost Management Insights: SG&A Expenses for Veracyte, Inc. and Geron Corporation
Cost Management Insights: SG&A Expenses for MorphoSys AG and Geron Corporation